|
Valiant Laboratories Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
471.76 Cr.
|
P/BV
|
1.49
|
Book Value (Rs.)
|
58.14
|
|
52 Week High/Low (Rs.)
|
119/75
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
19/07/2025
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 |
| | | | |
| PER SHARE RATIOS | | | |
| | | | |
| Basic EPS (Rs.) | -0.51 | 0.13 | 8.91 |
| Diluted EPS (Rs.) | -0.51 | 0.13 | 8.91 |
| Cash EPS (Rs.) | -0.02 | 0.52 | 9.39 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 53.93 | 54.51 | 30.86 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 53.93 | 54.51 | 30.86 |
| Revenue From Operations / Share (Rs.) | 30.70 | 41.90 | 102.55 |
| PBDIT / Share (Rs.) | 0.17 | 0.29 | 12.27 |
| PBIT / Share (Rs.) | -0.30 | -0.15 | 11.79 |
| PBT / Share (Rs.) | -0.34 | -0.17 | 11.71 |
| Net Profit / Share (Rs.) | -0.50 | 0.07 | 8.91 |
| NP After MI And SOA / Share (Rs.) | -0.50 | 0.07 | 8.91 |
| | | | |
| PROFITABILITY RATIOS | | | |
| | | | |
| PBDIT Margin (%) | 0.56 | 0.69 | 11.96 |
| PBIT Margin (%) | -1.00 | -0.37 | 11.49 |
| PBT Margin (%) | -1.13 | -0.42 | 11.42 |
| Net Profit Margin (%) | -1.65 | 0.17 | 8.68 |
| NP After MI And SOA Margin (%) | -1.65 | 0.17 | 8.68 |
| Return on Networth / Equity (%) | -0.93 | 0.13 | 28.85 |
| Return on Capital Employeed (%) | -0.39 | -0.22 | 23.66 |
| Return On Assets (%) | -0.54 | 0.09 | 13.61 |
| Long Term Debt / Equity (X) | 0.44 | 0.31 | 0.59 |
| Total Debt / Equity (X) | 0.51 | 0.32 | 0.59 |
| Asset Turnover Ratio (%) | 0.35 | 0.65 | 0.00 |
| | | | |
| LIQUIDITY RATIOS | | | |
| | | | |
| Current Ratio (X) | 3.23 | 7.76 | 2.97 |
| Quick Ratio (X) | 3.16 | 7.41 | 2.71 |
| Inventory Turnover Ratio (X) | 19.05 | 14.69 | 0.00 |
| | | | |
| COVERAGE RATIOS | | | |
| | | | |
| Interest Coverage Ratio (%) | 4.31 | 16.37 | 157.30 |
| Interest Coverage Ratio (Post Tax) (%) | -11.56 | 5.11 | 115.17 |
| | | | |
| VALUATION RATIOS | | | |
| | | | |
| Enterprise Value (Cr.) | 378.87 | 602.47 | 0.00 |
| EV / Net Operating Revenue (X) | 2.84 | 3.31 | 0.00 |
| EV / EBITDA (X) | 501.61 | 472.97 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 2.50 | 3.47 | 0.00 |
| Price / BV (X) | 1.42 | 2.67 | 0.00 |
| Price / Net Operating Revenue (X) | 2.50 | 3.47 | 0.00 |
| EarningsYield | -0.01 | 0.00 | 0.00 |
